Marshall Wace
INDV icon

Marshall Wace’s Indivior Pharmaceuticals INDV Stock Holding History

Marshall Wace’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-647,555
Closed -$23.2M – 3446
2025
Q4 		$23.2M Sell
647,555
-243,534
-27% -$7.44M 0.02% 584
2025
Q3 		$21.5M Buy
+891,089
New +$18.6M 0.02% 626
2025
Q2 		– Sell
-394,841
Closed -$3.76M – 2922
2025
Q1 		$3.76M Sell
394,841
-111,941
-22% -$1.18M 0.01% 1195
2024
Q4 		$6.3M Buy
506,782
+440,072
+660% +$4.53M 0.01% 967
2024
Q3 		$650K Sell
66,710
-7,022
-10% -$82.2K ﹤0.01% 1833
2024
Q2 		$1.19M Buy
73,732
+61,302
+493% +$1.11M ﹤0.01% 1611
2024
Q1 		$266K Buy
+12,430
New +$233K ﹤0.01% 2155

Other funds holding INDV

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return